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Abstract 
Effective and controlled drug delivery systems with on-demand release and targeting abilities 
have received enormous attention for biomedical applications. Here, we describe a novel 
enzyme-based cap system for mesoporous silica nanoparticles (MSNs) that is directly combined 
with a targeting ligand via bio-orthogonal click chemistry. The capping system is based on the 
pH-responsive binding of an aryl-sulfonamide-functionalized MSN and the enzyme carbonic 
anhydrase (CA). An unnatural amino acid (UAA) containing a norbornene moiety was genetically 
incorporated into CA. This UAA allowed for the site-specific bio-orthogonal attachment of even 
very sensitive targeting ligands such as folic acid and anandamide. This leads to specific 
receptor-mediated cell and stem cell uptake. We demonstrate the successful delivery and 
release of the chemotherapeutic agent Actinomycin D to KB cells. This novel nanocarrier 
concept provides a promising platform for the development of precisely controllable and highly 
modular theranostic systems. 
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Introduction 
The development of effective systems for targeted drug delivery combined with on demand 
release behavior can be considered one of the grand challenges in nanoscience. In particular, 
porous nanocarriers with high drug loading capacity, immunological stealth behavior and 
tunable surface properties are promising candidates for biomedical applications such as cancer 
therapy and bioimaging.1-4 Specifically, multifunctional mesoporous silica nanoparticles (MSNs) 
have great potential in drug delivery applications due to their attractive porosity parameters 
and the possibility to conjugate release mechanisms for diverse cargos5, 6 including gold 
nanoparticles,7, 8 iron oxide nanocrystals,9 bio-macromolecules,10, 11 enzymes,12 and polymers.13 
Control over a stimuli-responsive cargo release can be achieved via different trigger 
mechanisms such as redox reactions,14 pH changes,15 light-activation,5 or change in 
temperature.6 Drug delivery vehicles equipped with acid-sensitive capping mechanisms are 
highly desirable for acidified target environments such as the translation from early to late 
endosomes, tumors, or inflammatory tissues.  
Here, we present genetically designed enzyme-capped MSNs that combine two important 
prerequisites for advances in drug delivery, namely stimuli-responsive drug release and specific 
cell targeting (Scheme 1). Specifically, these pH-responsive MSNs consist of a capping structure 
based on carbonic anhydrase (CA). CA is a model enzyme abundant in humans and animals and 
generally catalyzes the hydration of carbon dioxide and the dehydration of bicarbonate.16 It is 
attached to the silica nanoparticle surface via aryl sulfonamide groups. As its natural inhibitor 
sulfonamide groups strongly bind to the active site of the CA. This enzyme-sulfonamide binding 
is reversible depending on the pH, where an acidic medium causes protonation of the 
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sulfonamide, resulting in cleavage of the coordination bond and access to the porous system.17 
The CA gatekeepers were used to exploit the endosomal pH change as an internal cellular 
trigger and to gain control over the release of cargo molecules from the mesoporous system.  
This stimuli-responsive capping system on MSNs was combined with cell targeting specificity via 
a bio-orthogonal click chemistry approach. Targeting ligands provide specific binding to certain 
cell membrane receptors allowing for an enhanced and distinctive cellular uptake of such 
modified nanocarriers. For example, various cell receptors are overexpressed on cancer cells, 
which can lead to a preferential receptor-mediated endocytosis of modified MSNs. For the 
attachment of such targeting ligands exclusively to the outer periphery of the enzyme 
gatekeepers, we exploited a recently developed method that takes advantage of the Pyrrolysine 
amber suppression system followed by bio-orthogonal copper-free click chemistry.18-20 This 
system has already been utilized in applications such as optical gene control.21 To the best of 
our knowledge, this is the first time the Pyrrolysine amber suppression system is used in a 
combination with porous nanocarriers for specific cell recognition and drug delivery. The 
incorporation of an unnatural amino acid (UAA) containing a norbornene moiety into CA 
provides a bio-orthogonal reaction pathway by covalently attaching tetrazine-modified targeting 
ligands.22, 23 It has recently been demonstrated that norbornene-tetrazine click chemistry is a 
favorable synthesis strategy over various other methods including thiol-maleimide reaction and 
amide formation due to extremely mild and biocompatible reaction conditions and higher 
selectivity.24 Here, copper-free click chemistry of norbornene-modified human carbonic 
anhydrase II with targeting ligands was performed to prepare folate- and anandamide-modified 
multifunctional mesoporous silica nanocarriers.25 The anandamide is, due the cis-configured 
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double bonds, a particularly sensitive receptor ligand that requires extremely mild coupling 
conditions. The targeting system based on folate-modified silica nanocarriers was studied on KB 
cancer cells, which are known to overexpress the folate receptor FR-α.5, 26 The targeting system 
based on anandamide-modified particles was tested on neural stem cells. The combination of 
on-demand release and specific receptor-mediated cell uptake properties within one 
multifunctional mesoporous silica nanocarrier system, containing biomolecular valves based on 
carbonic anhydrase, is anticipated to offer promising potential for controlled drug delivery 
applications including cancer therapy.  
 
Scheme 1: Schematic illustration of the genetically designed biomolecular pore gating system providing a pH-responsive drug 
release from mesoporous silica nanoparticles (MSNs). Aryl sulfonamide functionalized MSNs offer pH-dependent reversible 
attachment of the bulky enzyme carbonic anhydrase, which efficiently blocks the pore entrances to prevent premature cargo 
release. Furthermore, specific cancer cell targeting can be achieved via site-specific modification of a genetically incorporated 
norbornene amino acid in the biomolecular gatekeepers. 
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Results and Discussion 
pH-Responsive MSNs with an average particle size of 150 nm (average pore diameter: 3.8 nm) 
containing biomolecular valves based on the enzyme carbonic anhydrase (CA, hydrodynamic 
diameter: 5.5 nm) were synthesized via a delayed co-condensation approach.27 An outer 
functional shell consisting of benzene sulfonamide groups (pHSA) acts as an anchor point for the 
enzymatic gatekeepers. The formation of the inhibitor-enzyme complex (phSA-CA) leads to a 
dense coating at the external particle surface (MSN-phSA-CA). The characterization of the 
particle system by dynamic light scattering (DLS), zeta potential measurements, transmission 
electron microscopy (TEM), nitrogen sorption isotherms, infrared and Raman spectroscopy 
confirms the successful synthesis of carbonic anhydrase-coated MSNs. In vial release 
experiments demonstrate efficient sealing of the pores with carbonic anhydrase acting as a 
bulky gatekeeper, preventing premature cargo release and allowing for release upon acid-
induced detachment of the capping system (for detailed information about synthesis and 
characterization see SI). 
For efficient receptor-mediated cancer cell uptake and selective drug delivery a targeting ligand 
needs to be implemented. Since the particle surface is covered with bulky enzymes (CA), we 
aimed for the attachment of the targeting moieties directly to the outer periphery of the 
enzyme, in order to be accessible for cell receptors. For this approach to be successful, the site 
of targeting ligand attachment on the enzyme is of key importance. Ideally it should be 
positioned opposite of the binding site of the enzyme, to prevent blocking of the active site and 
thus leakage of the capping system. However, site-specific chemical modifications of proteins 
are highly challenging. Several methods, such as the reaction of thiol groups with maleimide or 
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of lysine chains with activated esters, lack specificity. A more specific method is the 
incorporation of unnatural amino acids into the protein.18, 28, 29 Among others, the genetic 
incorporation of UAAs bearing side chains with alkyne,30, 31 trans-cyclooctene,32 cyclooctyne33 or 
norbornene18, 22 functionalities has been reported previously. Subsequently these residues can 
be modified specifically and bio-orthogonally, for example by reverse electron-demanding Diels-
Alder reactions with tetrazines.23, 24, 32 The natural PylRS/tRNAPyl pair is perfectly suitable to 
genetically incorporate UAAs due to its orthogonality to common expression strains. Recently, a 
norbornene-containing Pyl analogue (Knorb) has been developed by some of us.18, 19 Here, the 
synthesis of norbornene-functionalized human carbonic anhydrase II (HCA) was accomplished 
similar to a previously described procedure yielding HCA H36Knorb.34 The correct position of the 
UAA was confirmed by tryptic digestion of the protein followed by HPLC-MS/MS analysis (see 
SI). HCA H36Knorb carrying norbornene on the opposite face of its phSA-binding site was bound 
to phSA-MSN and then treated with an excess of folate-PEG2000-tetrazine (Figure 1) or 
anandamide-tetrazine. The excess of the tetrazine reagent could be easily removed by 
centrifugation of the nanoparticles followed by washing. The efficiency of the folate-targeting 
system was examined on KB-cells presenting either free or blocked FA-receptors (Figure 1). For 
visualization, the cell membrane of the KB cells was stained with WGA488 (green), and the 
particles were labeled with Atto633 (red). In Figure 1c-e we present the folic acid receptor 
blocked cells that were incubated with particles between 2 and 8 h. With increasing incubation 
time, only a few particles were internalized and unspecific cell uptake was observed only to a 
minor degree. In contrast, the cells with available folic acid receptor on their surface (Figure 1f-
h) exhibit a significant and increasing uptake behavior and a considerably higher degree of 
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internalized particles. Thus we could confirm the successful application of bioorthogonal 
modification of a capping enzyme to act as targeting ligand. We also proved, that the here 
described genetically modified enzyme capping strategy can be used to attach even sensitive 
ligands like arachidonic acid via mild click-chemistry conditions e.g. for the site-specific targeting 
of neural stem cells.35 We tested the anandamide-targeting system on neural stem cells. Neural 
stem cells have anandamide receptors and successfully internalized the anandamide-particles 
(see SI). 
 
 
 
a) 
b) 
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Figure 1: a) Norbornene-functionalized carbonic anhydrase (HCA H36Norb) with indicated functionalization site (red) and 
active site (blue) is able to react in a reversed-electron-demand Diels-Alder reaction with a folate-PEG2000-tetrazine 
derivative to give HCA-FA. b) Schematic receptor-mediated uptake of folate-functionalized MSN-CA nanoparticles. c-e) 
Nonspecific and f-h) receptor-mediated endocytosis of MSN-phSA-CA-FA (red) by KB cells (WGA488 membrane staining, 
green). A specific receptor-mediated cell uptake was observed for MSN-phSA-CA-FA with KB cells (not pre-incubated with FA) 
after 5 and 8 h incubation at 37 °C (g/h). Incubation of MSN-phSA-CA-FA with FA-pre-incubated KB cells for 2, 5, 8 h at 37 °C 
showed only minor unspecific cellular uptake over all incubation times (c-e). The scale bar represents 10 μm. 
 
In vitro release experiments with the model cargo DAPI demonstrate a substantial time-
dependent release behavior from the mesopores of our nanocarrier system in HeLa cells (Figure 
S10). Additional co-localization experiments showed the localization of CA-capped nanoparticles 
in acidic cell compartments after endocytosis (Figure S11). To examine the ability of our newly 
developed MSN drug delivery system to transport chemotherapeutics and to affect cells with 
their cargo, we incorporated Actinomycin D (AmD), a cytostatic antibiotic, dissolved in DMSO. 
Free AmD is membrane permeable and induced an uncontrolled cell death within a few hours. 
MSN-phSA-CA provided intracellular AmD release and caused efficient cell death after 24 h. The 
delayed reaction demonstrates that AmD was delivered in a controlled manner via the particles 
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and released only after acidification of the endosome and subsequent de-capping of the gate-
keeper CA. In Figure 2 cell death is visualized by a caspase 3/7 stain - a marker for 
apoptotic/dead cells. Control particles loaded with pure DMSO did not induce cell death at all, 
nor did the supernatant solution after particle separation via centrifugation (Figure 2i-l). This 
experiment shows the great potential of the MSN-phSA-CA system to efficiently deliver 
chemotherapeutics to cancer cells. The pH-responsive genetically modified capping system 
provides the ability to act as a general platform for different targeting ligands and cargos. 
 
 
Figure 2: Representative fluorescence microscopy images of HeLa cells incubated with MSN-phSA-CA nanoparticles loaded 
with Actinomycin D (AmD; a-d) or DMSO (e-h) and labeled with Atto 633 (red) after 24 h of incubation. As a control, the 
supernatant of AmD loaded particles after particle separation was incubated with the cells (i-l). Cell nuclei were stained with 
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Hoechst 33342 (blue). For live/dead discrimination CellEvent caspase 3/7 (green) was used. Due to activation of caspase-3/7 
in apoptotic cells, DNA can be stained after cleavage of the DNA-binding dye from a binding-inhibiting peptide. MSNs were 
efficiently taken up by cells (c/d and g/h). Cell death can only be observed for cells treated with AmD loaded MSN-phSA-CA 
after 24 h of incubation (increased DNA staining in green) (b). In contrast, nanoparticles loaded with DMSO or the sample 
supernatant do not induce significant apoptosis (almost no DNA-staining) (f and j). The scale bars represent 50 µm. 
 
Conclusions  
We conclude that the novel capping system concept based on pH-responsive detachment of 
carbonic anhydrase combined with folic acid as targeting ligand allows for highly controllable 
drug release from porous nanocarriers. Our drug delivery system provides an on-demand 
release mechanism shown by in vial and in vitro cargo release experiments. The multifunctional 
MSNs were efficiently endocytosed in cancer cells and could be located in acidic cell 
compartments where they released their cargo. Furthermore, the system has an on-board 
targeting mechanism as demonstrated in additional in vitro experiments. The targeting 
mechanism is attached at a specific site of the capping enzyme preventing interference with the 
closure mechanism. Our newly developed pH-responsive gatekeepers with genetically designed 
targeting functions provide a promising platform for the design of versatile and modular drug 
delivery systems. 
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Supporting Information  
  
Experimental Part 
Materials. Tetraethyl orthosilicate (TEOS, Fluka, > 99 %), triethanolamine (TEA, Aldrich, 
98 %), cetyltrimethylammonium chloride (CTAC, Fluka, 25 % in H2O), (3-mercaptopropyl)-
triethoxysilane (MPTES, Sigma Aldrich, > 80 %), 6-maleimidohexanoic acid N-
hydroxysuccinimide ester (Fluka, > 98 %), bovine carbonic anhydrase (bCA, Sigma, > 95 %), 4-
(2-aminoethyl)benzenesulfonic acid (Aldrich, 98 %), folic acid (FA, Sigma Aldrich, ≥ 97 %,), 
4,6-Diamidino-2-phenylindole dihydrochloride (DAPI, Sigma-Aldrich, ≥ 98 %), CellEvent™ 
Caspase-3/7 Green Detection Reagent (lifeTechnologies), Hoechst 33342, Trihydrochloride, 
Trihydrate  (lifeTechnologies), Wheat Germ Agglutinin, Alexa Fluor® 488 Conjugate 
(lifeTechnologies), CellLight© Early Endosome-GFP, Late Endosome-GFP, and Lysosome-GFP, 
BacMam 2.0 (lifeTechnologies), Atto 633 maleimide (ATTO-TEC), ammonium nitrate 
(NH4NO3, Aldrich), ammonium fluoride (NH4F, Aldrich), hydrochloric acid (37 %), fluorescein 
disodium salt dihydrate (Aldrich, 90 %), and Hank´s balanced salt solution (HBSS-buffer, Sigma 
Aldrich) were used as received. Ethanol (EtOH, absolute, Aldrich), DMSO and 
dimethylformamide (DMF, dry, Aldrich) were used as solvent without further purification. 
Bidistilled water was obtained from a millipore system (Milli-Q Academic A10). Citric-acid 
phosphate buffer (CAP-buffer, pH 5.5) was freshly prepared by carefully mixing a certain 
amount of disodium hydrogen phosphate (Na2HPO4, 0.2 M in H2O) and citric acid (0.2 M in 
H2O) to adjust a pH value of 5.5. Subsequently, the solution was diluted with bidistilled H2O to a 
total volume of 500 mL.  
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Synthesis of thiol-functionalized MSNs (MSN-SH). A mixture of TEOS (1.92 g, 9.22 mol) and 
TEA (14.3 g, 95.6 mmol) was heated to 90 °C for 20 min under static conditions in a 
polypropylene reactor. Then, a preheated (60 °C) mixture of CTAC (2.41 mL, 1.83 mmol, 25 % 
in H2O) and NH4F (100 mg, 0.37 mmol) in bidistilled H2O (21.7 g, 1.21 mol) was added and the 
resulting reaction mixture was stirred vigorously (700 rpm) for 30 min while cooling down to 
room temperature. Afterwards, TEOS (18.2 mg, 92 µmol) and MPTES (18.1 mg, 92 µmol) were 
premixed briefly before addition to the reaction mixture. The final reaction mixture was stirred 
over night at room temperature. After dilution with absolute ethanol (100 mL), the nanoparticles 
were collected by centrifugation (19,000 rpm, 43,146 rcf, 20 min) and redispersed in absolute 
ethanol. Template extraction was performed in an ethanolic solution of MSNs (100 mL) 
containing NH4NO3 (2 g) which was heated at reflux conditions (90 °C oil bath) for 45 min. This 
was followed by a second extraction step (90 mL absolute ethanol and 10 mL hydrochloric acid 
(37 %)) under reflux conditions for 45 min (the material was washed with absolute ethanol after 
each extraction step and collected by centrifugation); finally the particles were redispersed in 
absolute ethanol and stored as colloidal suspension. 
Synthesis of sulfonamide-functionalized MSNs (MSN-phSA). For the covalent attachment of a 
sulfonamide derivative to the external particle surface, a thiol-reactive linker was synthesized. 6-
maleimidohexanoic acid N-hydroxysuccinimide ester (mal-C6-NHS, 10 mg, 33 µmol) was 
dissolved in DMF (500 µL, dry) and was added to an ethanolic solution (15 mL) containing 4-(2-
aminoethyl)benzene sulfonamide (6.7 mg, 33 µmol). The resulting reaction mixture was stirred 
for 1 h at room temperature. Afterwards, thiol-functionalized silica nanoparticles (MSN-SH, 
100 mg) in absolute ethanol (10 mL) were added and the mixture was stirred over night at room 
temperature. Subsequently, the particles were collected by centrifugation (19,000 rpm, 
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41,146 rcf, 20 min), washed twice with absolute ethanol and were finally redispersed in ethanol 
(15 mL) to obtain a colloidal suspension. 
Cargo loading and particle capping. MSNs (MSN-phSA, 1 mg) were immersed in an aqueous 
solution of fluorescein (1 mL, 1 mM), DAPI (500 µL, 14.3 mM) or Actinomycin D (500 µL 
[14 v% DMSO], 140 µM) and stirred over night or for 1 h, respectively. After collection by 
centrifugation (14,000 rpm, 16,837 rcf, 4 min), the loaded particles were redispersed in a HBSS 
buffer solution (1 mL) containing carbonic anhydrase (1 mg) and the resulting mixture was 
allowed to react for 1 h at room temperature under static conditions. The particles were 
thoroughly washed with HBSS buffer (4 times), collected by centrifugation (5,000 rpm, 
2,200 rcf, 4 min, 15 °C), and finally redispersed in HBSS buffered solution. 
Synthesis of Knorb. The norbornene containing amino acid Knorb was synthezised as described 
in Ref.
[1]
 
Mutagenesis of pACA_HCA H36amber. Adapted from Ref. 
[2]
 with permission from The 
Royal Society of Chemistry. The amber codon (TAG) was introduced into the expression vector 
pACA_HCA
[3]
 at position His36 of the human carbonic anhydrase II gene by blunt end site 
directed mutagenesis using the primers forward HCA H36amber and reverse HCA H36amber 
(see Table S1). 
Table S1: Sequences of the used primers for the generation of expression vector pACA_HCA H36amber. 
The introduced Amber codon is shown in bold. 
Name Sequence 
forward HCA H36amber 5’phosph GTT GAC ATC GAC ACT TAG ACA GCC AAG TAT GAC 
reverse HCA H36amber 5’phosph AGG GGA CTG GCG CTC TCC CTT GG 
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Expression of norbornene-containing HCA. Adapted from Ref.
[2]
 with permission from The 
Royal Society of Chemistry. The expression vector pACA_HCA G131amber was transformed 
together with pACyc_pylRS Norb, 3xpylT
[1]
 which contains the genes of the triple mutant of 
PylRS and three copies of pylT in E. coli BL21(DE3) cells (NEB). 1 L of LB medium containing 
34 mg/L chloramphenicol, 100 mg/L carbenicillin and 2 mM norbornene amino acid Knorb was 
inoculated with 10 mL of an overnight culture. The cells were stirred at 37 °C until an OD600 of 
0.9. At this optical density 1 mM ZnSO4 and 0.1 mM IPTG were added to induce the expression 
of the HCA H36amber gene. After further 10 h at 37 °C the cells were harvested and stored at -
20 °C until further use. The harvested cells were resuspended in washing buffer (25 mM Tris; 
50 mM Na2SO4; 50 mM NaClO4; pH 8.8) and disrupted by French Press procedure. The 
supernatant of the centrifuged lysate was used for sulfonamide affinity protein purification using 
an ÄKTA purifier system. The self-packed 3 mL column of p-Aminomethylbenzenesulfonamide-
Agarose resin (Sigma-Aldrich, A0796) was equilibrated with washing buffer. After binding 
(0.75 mL/min) of the protein solution, the column was washed with 7 column volumes of 
washing buffer. HCA was eluted by lowering the pH by elution buffer (100 mM NaOAc; 
200 mM NaClO4; pH 5.6). The protein containing fractions were combined, analyzed by SDS-
PAGE, dialyzed against water and lyophilized. Typical yields of the pure norbornene amino 
acid Knorb containing protein HCA H36Knorb were 20 mg/L expression medium.  
Tryptic digestion and MS/MS of norbornene-containing HCA. Adapted from Ref. 
[2]
 with 
permission from The Royal Society of Chemistry. The sequence of HCA II is shown in Table S2. 
Position His36 which was chosen for the incorporation of amino acid Knorb is shown in red. The 
peptide generated after tryptic digestion is emphasized in bold letters. Figure S1 shows the 
corresponding MS/MS spectrum. Table S3 shows the expected and identified MS/MS fragments 
of the relevant tryptic peptide. 
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Table S2: Amino acid sequence of HCA II.  
        10         20         30         40         50         60  
MAHHWGYGKH NGPEHWHKDF PIAKGERQSP VDIDTHTAKY DPSLKPLSVS YDQATSLRIL  
 
        70         80         90        100        110        120  
NNGHAFNVEF DDSQDKAVLK GGPLDGTYRL IQFHFHWGSL DGQGSEHTVD KKKYAAELHL  
 
       130        140        150        160        170        180  
VHWNTKYGDF CKAVQQPDGL AVLGIFLKVG SAKPGLQKVV DVLDSIKTKG KSADFTNFDP  
 
       190        200        210        220        230        240  
RGLLPESLDY WTYPGSLTTP PLLESVTWIV LKEPISVSSE QVLKFRKLNF NGEGEPEELM  
 
       250        260  
VDNWRPAQPL KNRQIKASFK 
 
 
Figure S1: MS/MS spectrum of the tryptic peptide QSPVDIDTXTAK (X = 4). Parent ion: [M+2H]
2+
calc. = 
726.8829, [M+2H]
2+
obs. = 726.8807 (ΔM = 3 ppm). 
Table S3: Expected and identified MS/MS fragments of the tryptic peptide QSPVDIDTXTAK 
(X = Knorb). Identified fragments are shown in red for b ions and blue for y ions. 
#1 b⁺ Seq. y⁺ #2 
1 129.06586 Q  12 
2 216.09789 S 1324.69949 11 
3 313.15066 P 1237.66746 10 
4 412.21908 V 1140.61469 9 
5 527.24603 D 1041.54627 8 
6 640.33010 I 926.51932 7 
7 755.35705 D 813.43525 6 
8 856.40473 T 698.40830 5 
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9 1134.56774 X 597.36062 4 
10 1235.61542 T 319.19761 3 
11 1306.65254 A 218.14993 2 
12  K 147.11281 1 
 
Click chemistry of norbornene-containing hCA. MSNs (MSN-phSA, 0.5 mg) were immersed 
in 500 µL HBSS buffer solution and 0.5 mg norbornene-containing hCA were added. In the 
meantime, 2.5 µg tetrazin p-benzylamine (DMSO stock solution, 0.92 mg/mL) and 0.41 mg 
NHS-PEG2000-FA were mixed in 100 µL HBSS and stirred overnight in the dark at room 
temperature. The solutions were mixed afterwards and stirred for two hours, washed several 
times and redispersed in 1 mL HBSS buffer. Subsequently, 1 µL Atto633mal (DMF stock 
solution, 0.5 mg/mL) was added and the mixture was stirred for 1 hour. The particles were 
thoroughly washed with HBSS buffer (4 times), collected by centrifugation (5,000 rpm, 
2,200 rcf, 4 min, 15 °C), and finally redispersed in HBSS buffered solution. 
Characterization. DLS and zeta potential measurements were performed on a Malvern Zetasizer 
Nano instrument equipped with a 4 mW He-Ne-Laser (633 nm) and an avalanche photodiode 
detector. DLS measurements were directly recorded in diluted colloidal suspensions of the 
particles at a concentration of 1 mg/mL. Zeta potential measurements were performed using the 
add-on Zetasizer titration system (MPT-2) based on diluted NaOH and HCl as titrants. For this 
purpose, 1 mg of the particles was diluted in 10 mL bi-distilled water. Thermogravimetric 
analyses (TGA) of the bulk extracted samples (approximately 10 mg) were recorded on a Netzsch 
STA 440 C TG/DSC. The measurements proceeded at a heating rate of 10 °C/min up to 900 °C 
in a stream of synthetic air of about 25 mL/min. Nitrogen sorption measurements were performed 
on a Quantachrome Instrument NOVA 4000e at -196 °C. Sample outgassing was performed for 
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12 hours at a vacuum of 10 mTorr at RT. Pore size and pore volume were calculated by a 
NLDFT equilibrium model of N2 on silica, based on the desorption branch of the isotherms. In 
order to remove the contribution of the interparticle textural porosity, pore volumes were 
calculated only up to a pore size of 8 nm. A BET model was applied in the range of 0.05 –
 0.20 p/p0 to evaluate the specific surface area. Infrared spectra of dried sample powder were 
recorded on a ThermoScientific Nicolet iN10 IR-microscope in reflexion-absorption mode with a 
liquid-N2 cooled MCT-A detector. Raman spectroscopy measurements were performed on a 
confocal LabRAM HR UV/VIS (HORIBA Jobin Yvon) Raman microscope (Olympus BX 41) 
with a SYMPHONY CCD detection system. Measurements were performed with a laser power 
of 10 mW at a wavelength of 633 nm (HeNe laser). Dried sample powder was directly measured 
on a coverslip. UV/VIS measurements were performed on a Perkin Elmer Lambda 1050 
spectrophotometer equipped with a deuterium arc lamp (UV region) and a tungsten filament 
(visible range). The detector was an InGaAs integrating sphere. Fluorescence spectra were 
recorded on a PTI spectrofluorometer equipped with a xenon short arc lamp (UXL-75XE 
USHIO) and a photomultiplier detection system (model 810/814). The measurements were 
performed in HBSS buffer solution at 37 °C to simulate human body temperature. For time-based 
release experiments of fluorescein a custom made container consisting of a Teflon tube, a dialysis 
membrane (ROTH Visking type 8/32, MWCO 14,000 g/mol) and a fluorescence cuvette was 
used. The excitation wavelength was set to λ = 495 nm for fluorescein-loaded MSNs. Emission 
scans (505 – 650 nm) were performed every 5 min. All slits were adjusted to 1.0 mm, bandwidth 
8 nm). Mass spectra were recorded a Thermo LTQ-Orbitrap XL. For analytical HPLC separations 
of protein and peptide samples with subsequent MS a Dionex Ultimate 3000 Nano HPLC was 
used. Acetonitrile of LC-MS grade was purchased from Carl Roth GmbH + Co. KG. Water was 
purified by a Milli-Q Plus system from Merck Millipore. 
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Synthesis of Anandamide-tetrazine 
Chemicals were purchased from Sigma-Aldrich, Fluka or Acros and used without further 
purification. Solutions were concentrated in vacuo on a Heidolph rotary evaporator. The solvents 
were of reagent grade and purified by distillation. Chromatographic purification of products was 
accomplished using flash column chromatography on Merck Geduran Si 60 (40-63 μM) silica gel 
(normal phase). Thin layer chromatography (TLC) was performed on Merck 60 (silica gel F254) 
plates. Visualization of the developed chromatogram was performed using fluorescence 
quenching or staining solutions. 
1
H and 
13
C NMR spectra were recorded in deuterated solvents on 
Bruker ARX 300, Varian VXR400S, Varian Inova 400 and Bruker AMX 600 spectrometers and 
calibrated to the residual solvent peak. Multiplicities are abbreviated as follows: s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, br. = broad. ESI spectra and high-resolution ESI 
spectra were obtained on the mass spectrometers Thermo Finnigan LTQ FT-ICR. IR 
measurements were performed on Perkin Elmer Spectrum BX FT-IR spectrometer (Perkin Elmer) 
with a diamond-ATR (Attenuated Total Reflection) setup. Repetencys are given in cm-1. The 
intensities are abbreviated as follows: vs (very strong), s (strong), m (medium), w (weak), vw 
(very weak).  
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Scheme S1: Synthesis of anandamide-tetrazine 4. a) 1. TFA, DCM, 0°C; 2. DIPEA, HATU, 
HOBt, DMF, RT, 42% b) 1. TFA, DCM, 0°C; 2. arachidonic acid, DIPEA, HATU, HOBt, RT, 
46%. 
tert-butyl (4-(6-(pyrimidin-2-yl)-1,2,4,5-tetrazin-3-yl)benzyl)carbamate (1) was synthesised 
according to the procedures described by Willems et al.
[1]
 
2,2-dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-oic acid (2) was synthesised like 
from Shirude et al described.
[2]
  
 
tert-butyl (3-oxo-1-(4-(6-(pyrimidin-2-yl)-1,2,4,5-tetrazin-3-yl)phenyl)-5,8,11,14-tetraoxa-2-
azahexadecan-16-yl)carbamate (3) 
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tert-butyl (4-(6-(pyrimidin-2-yl)-1,2,4,5-tetrazin-3-yl)benzyl)carbamate (1) (162 mg, 
0.160 mmol) was dissolved in 6.4 mL DCM and cooled to 0°C before TFA (1.6mL) were added. 
After 45 min the solvent was removed in vacuo and the resulting residue was used in the next 
reaction without further purification.  
2,2-dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-oic acid (2) (228 mg, 
0.649 mmol, 2.5 eq.) was diluted in 3.77 mL dry DMF and HATU (119 mg, 0.312 mmol, 
1.2 eq.), HOBt (102 mg, 0.780 mmol, 3 eq.) and finally DIPEA (0.192 mL, 0.780 mmol, 3 eq.) 
were added. After 10 min the deprotected tetrazinamine (0.068 mg, 0.260 mmol, 1 eq.) was 
added and the reaction was stired over night at RT. The reaction was diluted with DCM and the 
washed with water and brine before the combined organic phases were dried over MgSO4 and the 
solvent was removed in vacuo. The residue was purified by column chromatography (silica, 
DCM/EtOAc/MeOH, 5:5:1) to obtain the 3 as violet oil (66.0 mg, 0.110 mmol, 42%). 
Rf = 0.22 (CH2Cl2/EtOAc/MeOH, 5:5:1). 
1
H-NMR (600 MHz, CDCl3): δ [ppm] = 9.11 (d, 
3
J = 4.9 Hz, 2H, 2xC-Harom), 8.68 (d, 
3
J = 8.4 Hz, 2H, 2xC2-Harom), 7.59 – 7.54 (m, 1H, C-Harom), 4.61 (d, 
3
J = 6.2 Hz, 2H, Ar-CH2-
NH), 4.12 – 4.08 (m, 2H, C=O-CH2-O), 3.73 – 3.50 (m, 14H, tetraethylene glycol 7x CH2), 3.47 
(t, 
3
J = 5.1 Hz, 2H, CH2-NH), 1.40 (s, 9H, 
3xCH3-tBu). 
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13
C-NMR (150 MHz, CDCl3): δ [ppm] = 164.57, 163.32, 159.82, 159.81, 158.62, 129.33, 
128.77, 122.68, 70.62, 70.36 (Tetraethylenglykol 7 x CH2), 42.76 (Ar-CH2-NH), 28.64 (CH3-
tBu). 
HR-MS (ESI): [M+Na]
+
 calc.: 621.2755, found: 621.2763. 
FT-IR (ATR, cm
-1
): 3336 (br, w), 2921 (w), 1702 (m), 1676 (m), 1610 (m), 1563 (m), 1529 (m), 
1434 (m), 1380 (vs), 1250 (m), 1144 (m), 1113 (m), 844 (s).  
14-((5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenamido)-N-(4-(6-(pyrimidin-2-yl)-1,2,4,5-tetrazin-3-
yl)benzyl)-3,6,9,12-tetraoxatetradecanamide (4) 
 
 
tert-Butyl (3-oxo-1-(4-(6-(pyrimidin-2-yl)-1,2,4,5-tetrazin-3-yl)phenyl)-5,8,11,14-tetraoxa-2-
azahexadecan-16-yl)carbamat (3) (66.0 mg, 0.1103 mmol) was solved in 1.15 mL DCM and 
0.3 mL TFA was added. After 45 min the solvent was removed in vacuo and the resulting residue 
was used in the next step without further purification.  
Arachidonic acide (54.6 µmol, 166 µmol, 1.5 eq.) was dissolved in 0.7 mL dry DMF and HATU 
(50.3 mg, 132 µmol, 1.2 eq.), HOBt (44.7 mg, 331 µmol, 3 eq.) and DIPEA (56,3 µL, 332 µmol, 
3 eq.) were added. After 10 min the deprotected amine (55.0 mg, 110 µmol, 1 Äquiv.), dissolved 
in 0.6 mL dry DMF, was added and the reaction was steered for 2h at RT. The reaction was 
diluted with DCM and washed with saturated NH4Cl-solution. After drying of the combined 
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organic phases over MgSO4 and removing of the solvent in vacuo, the residue was purified by 
column chromatography (silica, iHex/EtOAc, 1:1 → DCM/EtOAc/MeOH, 10:10:1). 4 was 
received as violet oil (39,6 mg, 50,6 µmol, 46%). 
Rf = 0.72 (CH2Cl2/EtOAc/MeOH, 2:2:1). 
1
H-NMR (600 MHz, CDCl3): δ [ppm] = 9.11 (d, 
3
J = 4.8 Hz, 2H, C-Harom), 8.67 (d, 
3
J = 8.4 Hz, 
2H, 2xC3‘-Harom), 7.59 – 7.54 (m, 1H, C5-Harom), 5.43 – 5.23 (m, 8H, 8xCH), 4.61 (d, 
3
J = 6.2 Hz, 2H, Ar-CH2-NH), 4.11 – 4.02 (m, 2H, C=O-CH2-O), 3.73 – 3.36 (m, 18H, 
tetraethylene glykole 8xCH2, CH2-NH), 2.82 – 2.72 (m, 6H, 3xC-H2arach), 2.18 – 2.12 (m, 2H, 
CH2arach), 2.09 – 1.99 (m, 4H, 2xC-H2arach), 1.67 (q, 
3
J = 7.5 Hz, 2H, C-H2arach), 1.37 – 1.20 (m, 
6H, 3xC-H2arach), 0.86 (t, J = 7.0 Hz, 3H, C-H3arach).  
13
C-NMR (100 MHz, CDCl3): δ [ppm] = 173.38 , 170.64, 164.54, 163.27, 159.72 (Cq), 158.64 
(2xCarom), 129.35 (CH), 129.33 (2xC), 128.90, 128.81, 128.74, 128.43, 128.38, 128.06, 127.72 
(7xCH), 126.95, 122.75 (Carom), 71.30, 70.65, 70.60, 70.47, 70.34, 70.13 (Tetraethylenglykol 
8xCH2), 42.73 (CH2-NH), 39.40, 36.21 (Carach), 31.72 (Carach), 29.92 (Carach), 27.43 (Carach), 26.91 
(Carach), 25.85 (Carach), 25.83 (Carach), 25.74 (Carach), 22.79 (Carach), 14.30 (Carach).  
HR-MS (ESI): [M+H]
+
 calc.: 785.4709, found: 785.4727. 
FT-IR (ATR, cm
-1
): 3311 (m), 2923 (s), 1555 (s), 1413 (s), 1103 (s). 
 
Click chemistry of norbornene-containing hCA with anandamide tetrazine. MSNs (MSN-
phSA, 0.5 mg) were loaded in 500 µL of calcein solution (1 mM) for 1 h. The loaded particles 
were collected by centrifugation (14,000 rpm, 16,837  rcf, 4 min) and 500 µL HBSS buffer 
solution was added. After addition of 0.5 mg norbornene-containing hCA the particles were 
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redispersed and stirred for 1 h. Then, 5 µg anandamide tetrazine (DMSO stock solution, 
2 mg/mL) were added and stirred for 1 h respectively. The particles were thoroughly washed with 
HBSS buffer (4 times), collected by centrifugation (5,000 rpm, 2,200 rcf, 4 min, 15 °C), and 
finally redispersed in 500 µL HBSS buffered solution. 
 
[1] Willems L.I.; Li N.; Florea B.I.; Ruben M.; Van Der Marel G.A.; Overkleeft H.S.  
Angewandte Chemie International Edition, 2012, 51, 4431 - 4434 
[2] Shirude P.S., Kumar V.A., Ganesh K.N., European Journal of organic Chemistry, 2005, 
24, 5207-5215. 
Cell Culture. HeLa cells were grown in Dulbecco’s modified Eagle’s medium (DMEM):F12 
(1:1) (lifeTechnologies) with Glutamax I medium and KB cells in folic acid deficient Roswell 
Park Memorial Institute 1640 medium (RPMI 1640, lifeTechnologies), both supplemented with 
10 % fetal bovine serum (FBS) at 37 °C in a 5 % CO2 humidified atmosphere. The cells were 
seeded on collagen A-coated LabTek chambered cover glass (Nunc). For live cell imaging the 
cells were seeded 24 or 48 h before measuring, at a cell density of 2x104 or 1x104 cells/cm
2
. 
The FGF-2 and EGF dependant neural stem cell line ENC1 was derived from E14 mouse 
embryonic stem cells and cultured as described.[9] ENC1 cells were maintained in gelatine 
coated flasks and propagated in a 1:1 mixture of Knockout-DMEM (Life Technologies) and 
Ham’s F-12 (Sigma) supplemented with 2 mM GlutaMAX-I (Life Technologies), 100 U/ml 
penicillin (Sigma), 100 mg/ml streptomycin (Sigma) 1% N2 and 20 ng/ml each of mouse 
recombinant FGF-2 and EGF (Peprotech). N2 supplement was produced in house as described, 
with the exception that Insulin was of human origin (Sigma I9278) instead of  bovine.[10]. Stem 
cells were seeded on ibidi 8-well µ-slides.  
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In vitro Cargo Release. Cells were incubated 7 – 24 h prior to the measurements at 37 °C under 
a 5% CO2 humidified atmosphere. Shortly before imaging, the medium was replaced by CO2-
independent medium (Invitrogen). During the measurements all cells were kept on a heated 
microscope stage at 37 °C. The subsequent imaging was performed as described in the spinning 
disk confocal microscopy section. 
Endosomal compartment staining. To stain the early/late endosome or the lysosome with GFP, 
commercially available CellLight© staining from lifeTechnologies was used . The cells were 
simultaneously incubated with MSNs and the BacMam 2.0 reagent. The concentration of the 
labeling reagent was chosen with 25 particles per cell (PCP) of the BacMam 2.0 reagent (cf. 
staining protocol 
[4]
). For incubation, the cells stayed at 37 °C under 5% CO2 humidified 
atmosphere for 21 – 24 h till the measurement. 
Caspase-3/7 staining. For apoptosis detection commercially available CellEvent™ Caspase-3/7 
Green Detection Reagent was used. A final concentration of 2.5 µM Caspase-3/7 reagent and 
0.5 µg/mL Hoechst 33342 were added to the cells for 30 min and imaging was performed without 
further washing steps. 
Uptake studies. The functionality of the folic acid targeting ligand was evaluated in a receptor 
competition experiment. For this purpose, one part of the KB cells was pre-incubated with 3 mM 
folic acid, to block the receptors, for 2 h at 37 °C under a 5% CO2 humidified atmosphere. Then 
the KB cells were incubated with particles for 2/5/8 h at 37 °C under a 5% CO2 humidified 
atmosphere. For staining the cell membrane, the cells were incubated with a final concentration 
of 10 μg/mL wheat germ agglutinin Alexa Fluor 488 conjugate for one minute. The cells were 
washed once with CO2-independent medium and imaged. For stem cell uptake studies cells were 
seeded the day prior to incubation. They were incubated for 2 h with free anandamide-tetrazine at 
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a final concentration of 10 µg/ml. After 2 h 15 µg of particles were added and incubated for 
another 2 h. Then, the cells were washed 3x with medium containing growth factors and if 
preincubated free anandamide-tetrazine and incubated until imaging. Immediately before 
imaging, cells membranes were stained using cell mask deep red (lifetechnologies) and washed 
with medium.  
Spinning disc confocal microscopy. Confocal microscopy for live-cell imaging was performed 
on a setup based on the Zeiss Cell Observer SD utilizing a Yokogawa spinning disk unit CSU-
X1. The system was equipped with a 1.40 NA 100x Plan apochromat oil immersion objective or 
a 0.45 NA 10x air objective from Zeiss. For all experiments the exposure time was 0.1 s and z-
stacks were recorded. DAPI and Hoechst 33342 were imaged with approximately 0,16 W/mm
2
 of 
405 nm, GFP was and the caspase-3/7 reagent were imaged with approximately 0.48 W/mm
2
 of 
488 nm excitation light. Atto 633 was excited with 11 mW/mm
2
 of 639 nm. In the excitation path 
a quad-edge dichroic beamsplitter (FF410/504/582/669-Di01-25x36, Semrock) was used. For two 
color detection of GFP/caspase-3/7 reagent or DAPI/Hoechst 33342 and Atto 633, a dichroic 
mirror (560 nm, Semrock) and band-pass filters 525/50 and 690/60 (both Semrock) were used in 
the detection path. Separate images for each fluorescence channel were acquired using two 
separate electron multiplier charge coupled device (EMCCD) cameras (PhotometricsEvolveTM) 
 
Further Characterization 
MSNs containing thiol-functionality exclusively at the external particle surface (sample MSN-
SH) were established following a previously described delayed co-condensation approach.
[5]
 In a 
second step, benzene sulfonamide (phSA) groups were covalently attached to the silica 
nanoparticles via a short bifunctional crosslinker (maleimide-C6-NHS) at mild reaction 
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conditions (sample MSN-phSA). After cargo loading, the enzyme CA was added to the buffered 
particle solution (pH 7.4). The formation of the inhibitor-enzyme complex (phSA-CA) leads to a 
dense coating at the external particle surface (MSN-phSA-CA).  
 
Figure S2: Characterization of multifunctional MSNs. a) Dynamic light scattering (DLS), b) zeta potential measurements, 
c) infrared (IR) spectroscopy data, d) Raman spectroscopy data, e) nitrogen sorption isotherms, and f) DFT pore size 
distribution of the MSNs. MSN-SH (black), MSN-phSA (red) and MSN-phSA-CA (green). 
Dynamic light scattering (DLS) measurements showed the size distribution of the functionalized 
MSNs to be narrow and around 150 nm (Figure S2a), implying excellent colloidal stability after 
all functionalization steps. The surface charge of silica nanoparticles, measured as the zeta 
potential, changed due to the stepwise attachment of organic moieties (Figure S2b): The 
isoelectric point (IEP) of MSN-SH (pH 3.6) was shifted to a more acidic pH value (< 2) for 
MSNs containing the benzene sulfonamide groups on the outer surface. The tendency for 
sulfonamide groups to be protonated is relatively low due to the stabilizing resonance effect, 
which leads to the increase in negative surface charge (predominantly influenced by silanol 
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content). After attachment of the carbonic anhydrase, a drastic increase of the zeta potential was 
observed resulting from amino acid residues that can be easily protonated - such as arginine, 
histidine and lysine - on the surface. IR data for all samples showed typical vibrational modes of 
the silica framework between 780 and 1300 cm
-1
 (Figure S2c). MSNs containing the benzene 
sulfonamide groups showed additional modes for C=O stretching vibrations at 1700 and 
1627 cm
-1
 and a peak of weak intensity at 1340 cm
-1
, which belongs to the typical asymmetric 
SO2 stretching vibration modes of the sulfonamide groups. For the sample MSN-phSA-CA, 
amide vibrations (Amide I: 1639 cm
-1
, C=O stretching vibration; Amide II: 1535 cm
-1
, N-H 
deformation and C-N stretching vibration) of high intensity were observed; these are typical for 
proteins. Raman spectroscopy provided data complementary to IR spectroscopy. In Figure S2d a 
more detailed view of the spectra for MSN-SH and MSN-phSA in the range between 1900 and 
600 cm
-1
 is depicted and various additional bands (*) were observed for the benzene 
sulfonamide-functionalized particles. (data for MSN-phSA-CA not shown, for full range Raman 
spectra see Figure S5). Nitrogen sorption measurements show type IV isotherms for MSN-SH 
and MSN-phSA, confirming mesoporosity of the silica nanoparticles. Relatively high surface 
areas (up to 1200 m²/g) and pore volumes (0.8 cm³/g) were observed for MSN-SH and MSN-
phSA (Table S4). 
Table S4: Porosity parameters of functionalized MSNs. 
Sample BET surface area (m²/g) Pore volume
a
 (cm³/g) DFT pore size
b
 (nm) 
MSN-SH 1170 0.83 3.8 
MSN-phSA 1004 0.72 3.7 
MSN-phSA-CA 99 0.07 - 
aPore volume is calculated up to a pore size of 8 nm to remove the contribution of interparticle porosity. 
bDFT pore size refers to the peak maximum of the pore size distribution. 
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Importantly, the DFT pore size distribution (Figure S2f) was not affected by the attachment of the 
benzene sulfonamide linkers and no incorporation of organic groups inside the mesopores was 
observed. The attachment of the bulky enzyme carbonic anhydrase resulted in a drastic reduction 
of surface area and pore volume for sample MSN-phSA-CA. Thus, the carbonic anhydrase 
enzymes were able to efficiently block the mesopores even towards the access of nitrogen 
molecules. We observed no pore size distribution for MSN-phSA-CA in the range between 2 and 
9 nm. This confirms the successful synthesis of carbonic anhydrase-coated MSNs via benzene 
sulfonamide linkers. 
 
 
Figure S3: Transmission electron micrograph of thiol-functionalized MSNs (MSN-SH). 
 
TEM images of thiol-functionalized MSNs are depicted in Figure S3 and display mostly 
spherically shaped particles with a radially disposed worm-like structure of the mesopores. The 
mesoporous structure is also confirmed by the first-order reflection of the mesoporous material 
observed with small-angle X-ray diffraction (XRD) (Figure S4). 
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Figure S4: Small-angle X-ray diffraction pattern of MSN-SH (black) and MSN-phSA (red). 
 
Full-range Raman spectra are shown in Figure S5. The sharp band at 1780 cm
-1
 can be assigned 
to the carbonyl stretching vibration of the diacylamine group of the maleimide residue that is 
covalently attached to the thiol groups of the MSN surface. The presence of phenyl groups is 
confirmed by characteristic bands of aromatic C=C stretching vibrations (1600 cm
-1
 and 1055 cm
-
1
) and aromatic =C-H out-of-plane deformation vibrations (693 cm
-1
). The broadening of the 
signal at 1600 cm
-1
 can be assigned to a partial overlap by amide II vibration modes. The bands at 
1326 and 1156 cm
-1
 are related to the characteristic asymmetric and symmetric stretching 
vibrations of the sulfonamide group, respectively. 
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Figure S5: Raman spectroscopy data of functionalized MSNs. MSN-SH (black) and MSN-phSA (red). For clarity reasons, 
the spectra are shifted along the y-axis by 0.1 units. Measurements were performed at an excitation wavelength of 633 nm. 
 
The amount of attached organic moieties on the MSNs was investigated by thermogravimetric 
analysis, showing an additional weight loss of about 14 % after attachment of CA (TGA, Figure 
S6). MSN-phSA particles show an additional weight loss of 3 % in the range between 130 and  
900 °C due to the attachment of the benzene sulfonamide linker and enzyme-coated MSNs 
(MSN-phSA-CA) feature a relatively high additional weight loss compared to sample MSN-SH 
(+14 % at 900 °C). Apparently, degradation of the carbonized enzymes occurs only at very high 
temperatures, and is not even finished at 900 °C. This was already observed before for 
thermogravimetric analysis of enzyme-coated MSNs.  
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Figure S6: Thermogravimetric analysis of MSN-SH (black), MSN-phSA (red), and MSN-phSA-CA (green).  
 
In order to investigate the pH-responsive removal of the bulky gatekeepers from the particles, in 
vial cargo release experiments were performed. We used a custom-made two-compartment 
system to analyze the time-based release of the fluorescent model cargo fluorescein.
[6]
 After 
incorporation of fluorescein molecules into the mesoporous system, carbonic anhydrase was 
added to block the pore entrances. An efficient sealing of the pores and no premature release of 
the cargo was observed for the sample MSN-phSA-CA dispersed in HBSS buffer (pH 7.4) at 
37 °C (Figure S7a, closed state, black curve). After 3 h the solution was exchanged and the 
particles were dispersed in citric-acid phosphate buffer (CAP buffer, pH 5.5). The change to 
acidic milieu, which simulates the acidification of endosomes, causes a significant increase in 
fluorescence intensity over time (open state, red curve). Furthermore, we could show the long-
term stability of the capping system for more than 16 hours in HBSS buffer and cell medium at 
pH 7.4 (Figure S7b). These in vial release experiments demonstrate efficient sealing of the pores 
with carbonic anhydrase acting as a bulky gatekeeper, preventing premature cargo release and 
allowing for release upon acid-induced detachment of the capping system. 
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Figure S7: In vial release kinetics of fluorescein molecules from the enzyme-coated MSNs at different pH values. (a) 
Sample MSN-pSA-CA features no premature release of the fluorescent cargo molecules in HBSS buffer solution at pH 7.4 
(closed state, black curve). After 3 h the medium was changed to slightly acidic milieu (CAP buffer, pH 5.5, red curve) 
resulting in a significant increase in fluorescence intensity. The gatekeepers are detached from the particle surface upon 
acidification, causing an efficient and precisely controllable release of fluorescein from the mesoporous system. (b) Long-
term stability of the capping system was investigated in HBSS buffer (pH 7.4, black curve) and cell medium (blue curve). 
No unintended cargo release was observed within about 16 h. 
 
 
Figure S8: Calibration curves of fluorescein at pH 7.4 (HBSS buffer, black curve) and pH 5.5 (CAP buffer, red curve). 
 
The enzyme activity assay investigates the hydrolysis in TRIS-buffered solution of a 
chromogenic substrate (p-nitrophenyl acetate, NPA) in the presence of the enzyme, generating 
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nitrophenol. UV-Vis spectroscopy is used to measure the resulting absorption maximum at 
400 nm. Figure S9 shows the resulting curve for the non-catalyzed (no carbonic anhydrase) 
reaction, which can be taken as baseline. The slight slope for this curve is due to the hydrolysis 
rate of the pure substrate in aqueous solution in the absence of catalytic enzymes. In the presence 
of 100 nM enzyme (non-inhibited) the maximum conversion of the substrate can be obtained. A 
slight decrease in conversion efficiency can be observed upon addition of 50 µg of MSN-SH 
particles due to marginal reduction of enzyme activity in the presence of silica nanoparticles. We 
assume that this effect corresponds to minor unspecific attachment of the carbonic anhydrase to 
the silica nanoparticles causing blocking of the active sites to some extent. In comparison, the 
addition of inhibitor-containing particles (MSN-phSA) causes a significant decrease of the slope 
of the resulting curve. This proves a specific formation of the inhibitor-enzyme complex at the 
external surface of the silica nanoparticles. Thus we have shown conclusively that the 
sulfonamide-functionalized MSNs are able to bind the enzyme carbonic anhydrase. At neutral pH 
values, the enzyme is specifically attached to the sulfonamide-functionalized particle surface 
resulting in an inhibition of the enzyme’s active site. This leads to a drastic decrease in enzyme 
activity. 
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Figure S9: Enzyme activity assay of CA catalyzing the hydrolysis of the chromogenic substrate p-nitrophenyl acetate 
measured by UV-Vis spectroscopy (absorbance at 400 nm). Non-catalyzed (green) and non-inhibited (blue) reaction and 
after addition of MSN-SH (black) or MSN-phSA (red). 
 
Employing fluorescent live-cell imaging, we investigated the in vitro release behavior of 
encapsulated 4’,6-diamidino-2-phenylindole (DAPI) in HeLa cancer cells. The molecular size of 
DAPI is similar to fluorescein. It was therefore expected to efficiently enter the mesoporous 
system of the silica nanoparticle. Due to its effective turn-on fluorescence upon intercalation into 
DNA double strands, DAPI is commonly used as nuclei counterstain in cell imaging (about 20 
fold enhancement in fluorescence intensity).
[7]
 Since DAPI is cell membrane permeable, free 
fluorescent dye molecules are able to stain the nucleus within very short time periods (1-5 min), 
as described in several staining protocols.
[8]
 After incorporation of DAPI into the mesoporous 
system of the silica nanocarriers, the pores were sealed by addition of carbonic anhydrase. The 
HeLa cells were incubated for a total time period of 24 h with the loaded particles, which were 
additionally labeled with Atto 633 dye (red), as depicted in Figure S10. After 7 h of incubation, 
MSNs were efficiently taken up by the cells and were found to be located in endosomes. 
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Importantly, almost no staining of the nuclei with DAPI (blue) could be observed at this time 
point. Only after 15 h, blue fluorescence (even more intensive after 24 h) provided evidence of 
efficiently released DAPI from the MSNs. Control experiments in which the sample supernatant 
after particle separation (centrifugation) was added to the HeLa cells showed no significant nuclei 
staining even after 24 h (Figure S10d). These cell experiments prove a substantial time-dependent 
release of DAPI from the mesopores of our nanocarrier system and also show that no free dye 
molecules were present in the solution. We suggest that the observed delayed nuclei staining 
results from a cascaded release mechanism. First, acidification throughout the endosomal 
pathway to late endosomes or endolysosomes is of key importance. Only the pH change to mildly 
acidic values (about 5.5) makes the detachment of the bulky gatekeepers from the MSN hosts 
possible. Subsequent opening of the pores leads to an efficient cargo release. 
 
 
Figure S10: Fluorescence microscopy of HeLa cells incubated with MSN-phSA-CA nanoparticles loaded with DAPI and 
labeled with Atto 633 (red) after a) 7 h, b) 12 h and c) 24 h of incubation. The delayed nuclei staining with DAPI (blue) is 
caused by a time-dependent release of DAPI based on the need for an acidic environment. d) In a control experiment, the 
incubation with the supernatant solution (without MSNs) showed no staining of the nuclei with DAPI after 24 h, 
suggesting that no free DAPI molecules were present in the particle solution. The nuclei are indicated with dashed circles. 
The scale bar represents 10 µm. 
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In order to verify the fate of our drug delivery vehicles ending up in acidic cell compartments, co-
localization experiments with labeled MSNs and endosomes or lysosomes were performed. 
Simultaneous with particle incubation, the HeLa cells were transfected with a BacMam reagent in 
order to express different fusion-constructs of green fluorescent protein (GFP) and early/late 
endosome or lysosome markers, respectively. After 24 h of incubation with fluorescently labeled 
nanoparticles, almost no co-localization (yellow) between early endosomes and MSNs could be 
observed, as can be seen in Figure S11a. In contrast, multiple yellow spots indicating co-
localization between GFP (green) and MSNs (red) were clearly visible in the case of late 
endosomal and lysosomal staining after 21 h (Figure S11b/c, denoted by arrows). This shows that 
the localization of our nanocarriers in an acidic compartment is crucial to initiate cargo release. 
 
 
Figure S11: Fluorescence microscopy of HeLa cells incubated with Atto 633-labeled MSN-phSA-CA (red) after a) 24 h on 
GFP-early endosome (green) tagged cells, b) 21 h incubation on GFP-late endosome (green) tagged cells, and c) 21 h on 
GFP-lysosome (green) tagged cells. Co-localization (yellow) could be primarily observed for late endosomes and lysosomes 
(indicated with arrows) suggesting that the multifunctional MSNs are located in acidic compartments after endocytosis. 
The scale bar represents 10 µm. 
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Stem Cell targeting 
To test targeting of anandamide functionalized particles neural stem cells were treated with 
anandamide functionalized particles. As control, cells were pretreated with free anandamide-
tetrazine and incubated with anandamide particles after 2 h of pretreatment. Another control was 
performed with control particles without anandamide functionalization. After two hours of 
particle incubation all cells were washed with medium. Already a few hours after incubation 
anandamide-particles were observed to stick to the cells in large amounts whereas particles 
without anandamide did not show this behavior. After 24h anandamide-targeted particles were 
successfully taken up into the cells. Cells that were incubated with control particles or 
preincubated with anandamide did not show as much particle uptake (Fig. S12).  
 
 
 
Figure S12: Fluorescence microscopy of neural stem cells incubated with calcein-labeled MSN-phSA-CA (green) after 24h 
a) incubated with anandamide-targeted MSN-phSA-CA, b) pretreated with free anandamide-tetrazine and incubated with 
anandamide targeted MSN-phSA-CA afterwards c) incubated with control MSN-phSA-CA without anandamide. Cell 
membranes are stained with cell mask deep red. The scale bar represents 10 µm. 
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